|
|
|
Insider
Information: |
Dowden Nathan J |
Relationship: |
President & COO |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
137,204 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
137,204 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Entrada Therapeutics, Inc. |
TRDA |
President & COO |
2024-03-06 |
137,204 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-07-11 |
4 |
AS |
$18.05 |
$70,333 |
D/D |
(3,897) |
35,376 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-07-10 |
4 |
AS |
$18.00 |
$57,605 |
D/D |
(3,200) |
39,273 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-06-22 |
4 |
AS |
$16.02 |
$113,700 |
D/D |
(7,097) |
42,473 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-10-31 |
4 |
AS |
$24.05 |
$50,495 |
D/D |
(2,100) |
45,283 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-10-25 |
4 |
AS |
$20.10 |
$194,191 |
D/D |
(9,348) |
47,383 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-09-06 |
4 |
AS |
$13.43 |
$13,089 |
D/D |
(972) |
48,168 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-09-05 |
4 |
D |
$14.46 |
$6,306 |
D/D |
(436) |
49,140 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-06-20 |
4 |
AS |
$14.94 |
$132,704 |
D/D |
(8,885) |
49,570 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,200 |
49,576 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-10-24 |
4 |
AS |
$18.88 |
$46,402 |
D/D |
(2,404) |
56,731 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-03-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
14,200 |
58,455 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-10-21 |
4 |
AS |
$18.29 |
$50,668 |
D/D |
(2,771) |
59,135 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating OfficerOfficer |
|
2021-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
61,344 |
|
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-10-20 |
4 |
AS |
$18.07 |
$16,357 |
D/D |
(905) |
61,906 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-09-26 |
4 |
AS |
$15.32 |
$23,854 |
D/D |
(1,544) |
62,811 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-09-23 |
4 |
AS |
$15.07 |
$15,341 |
D/D |
(1,018) |
64,355 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-06-27 |
4 |
AS |
$13.00 |
$100,282 |
D/D |
(7,714) |
64,893 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-09-21 |
4 |
AS |
$15.13 |
$49,537 |
D/D |
(3,275) |
65,373 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-09-15 |
4 |
AS |
$15.01 |
$1,501 |
D/D |
(100) |
68,648 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-09-09 |
4 |
AS |
$15.06 |
$13,031 |
D/D |
(865) |
68,748 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-09-08 |
4 |
AS |
$15.15 |
$13,814 |
D/D |
(912) |
69,613 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,632 |
70,525 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,263 |
72,607 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-03-02 |
4 |
D |
$11.60 |
$11,921 |
D/D |
(1,028) |
72,655 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Chief Operating Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,400 |
73,683 |
0 |
- |
|
29 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|